Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2822 | 2064 | 29.0 | 67% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
630 | 13104 | CYTOMEGALOVIRUS//HUMAN CYTOMEGALOVIRUS//HHV 6 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CONGENITAL INFECTION | Author keyword | 90 | 46% | 7% | 144 |
2 | CONGENITAL CYTOMEGALOVIRUS INFECTION | Author keyword | 73 | 75% | 3% | 53 |
3 | CYTOMEGALOVIRUS | Author keyword | 54 | 11% | 22% | 455 |
4 | CONGENITAL CYTOMEGALOVIRUS | Author keyword | 46 | 82% | 1% | 27 |
5 | CONGENITAL CMV | Author keyword | 41 | 85% | 1% | 22 |
6 | CONGENITAL CMV INFECTION | Author keyword | 21 | 69% | 1% | 18 |
7 | LENTICULOSTRIATE VASCULOPATHY | Author keyword | 14 | 100% | 0% | 7 |
8 | POSTNATAL CYTOMEGALOVIRUS INFECTION | Author keyword | 11 | 100% | 0% | 6 |
9 | CONGENITAL CYTOMEGALOVIRUS DISEASE | Author keyword | 6 | 80% | 0% | 4 |
10 | CONGENITAL INFECTIONS | Author keyword | 6 | 39% | 1% | 12 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TO MOTHER TRANSMISSION | 90 | 96% | 1% | 27 |
2 | CMV INFECTION | 57 | 29% | 8% | 167 |
3 | CONGENITAL CYTOMEGALOVIRUS | 23 | 52% | 2% | 32 |
4 | SYMPTOMATIC CONGENITAL CYTOMEGALOVIRUS | 18 | 89% | 0% | 8 |
5 | RETROSPECTIVE DIAGNOSIS | 17 | 72% | 1% | 13 |
6 | CYTORNEGALOVIRUS | 17 | 100% | 0% | 8 |
7 | CONGENITAL CYTOMEGALOVIRUS INFECTION | 16 | 21% | 3% | 67 |
8 | RECURRENT MATERNAL INFECTION | 15 | 82% | 0% | 9 |
9 | CONGENITAL CMV INFECTION | 15 | 68% | 1% | 13 |
10 | GANCICLOVIR THERAPY | 15 | 29% | 2% | 42 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The "Silent" Global Burden of Congenital Cytomegalovirus | 2013 | 55 | 186 | 84% |
Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection | 2007 | 289 | 67 | 97% |
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection | 2010 | 164 | 114 | 85% |
New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection | 2007 | 214 | 26 | 100% |
Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection | 2011 | 42 | 96 | 78% |
The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model | 2013 | 15 | 40 | 93% |
Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy | 2011 | 31 | 35 | 97% |
Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: A quantitative assessment | 2008 | 93 | 26 | 65% |
Prevention of Transfusion-Transmitted Cytomegalovirus Infections: Which Is the Optimal Strategy? | 2014 | 4 | 22 | 77% |
EPIDEMIOLOGICAL IMPACT AND DISEASE BURDEN OF CONGENITAL CYTOMEGALOVIRUS INFECTION IN EUROPE | 2009 | 42 | 53 | 94% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ST ORSOLA MALPIGHI GEN HOSP | 5 | 36% | 0.6% | 12 |
2 | MED VIROL EPIDEMIOL VIRAL DIS | 5 | 27% | 0.8% | 17 |
3 | SC OSTETRICIA GINECOL | 5 | 63% | 0.2% | 5 |
4 | OPERAT UNIT OBSTET PRENATAL MED | 3 | 100% | 0.1% | 3 |
5 | SUB SOCIAL PEDIAT | 3 | 60% | 0.1% | 3 |
6 | SERV MICROBIOL IMMUNOL BIOL | 2 | 24% | 0.4% | 9 |
7 | BIOL MOL MARCEL DASSAULT | 2 | 67% | 0.1% | 2 |
8 | DIS EAR NOSE THROAT | 2 | 67% | 0.1% | 2 |
9 | MED VIROL EPIDEMIOL VIRUSERKRANKUNGEN | 2 | 67% | 0.1% | 2 |
10 | OPERAT UNIT MICROBIOL VIROL | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000137310 | HUMAN CYTOMEGALOVIRUS//HCMV//US28 |
2 | 0.0000114573 | FLUOROSCEIN ISOTHIOCYANATE//INFLUENZA A H1N12009//LUCIFER YELLOW CARBOHYDRAZIDE |
3 | 0.0000114168 | IG LEVELS//LEUKEMIC CHILDREN//PROGNOSIS SURVIVAL |
4 | 0.0000110624 | CYTOMEGALOVIRUS//VALGANCICLOVIR//GANCICLOVIR |
5 | 0.0000073589 | CYTOMEGALOVIRUS COLITIS//CYTOMEGALOVIRUS ENTERITIS//CMV COLITIS |
6 | 0.0000066647 | MURINE CYTOMEGALOVIRUS//MCMV//LY49H |
7 | 0.0000064268 | VEGETABLE CELLS//ANAT PATHOL SERV 2//CICLO FORMAT ANAT PATOL CITOL |
8 | 0.0000055719 | CONGENITAL RUBELLA SYNDROME//RUBELLA VIRUS//RUBELLA |
9 | 0.0000048007 | CMV SPECIFIC T CELLS//ONCOHEMATOL GRP//CYTOMEGALOVIRUS SPECIFIC T CELLS |
10 | 0.0000034191 | CONGENITAL TOXOPLASMOSIS//TOXOPLASMOSIS//OCULAR TOXOPLASMOSIS |